Rail-Based Automation Fortifies an
AI-Enabled Drug Discovery Learning Loop
Traditional drug discovery methods yield limited progress over long periods of time. Exscientia recognized this as a major roadblock and sought to reimagine this critical step in developing therapies to improve patient lives. Download this case study now to see how looping in automation enabled them to navigate this roadblock and meet their goals of increasing the learning loop rate, building economies of scales and supporting improved workflow reliability and repeatability.
Inside, you will:
Ready to learn more? Simply fill out the form and unlock the secrets to true automation.
"We are aiming at multiple assets on the system per day, which requires considerable automation flexibility."
Martin Redhead, PhD.
Executive Director, Primary Pharmacology